Phytosterols reverse antiretroviral-induced hearing loss, with potential implications for cochlear aging
2023
Sodero, Alejandro O. | Castagna, Valeria C. | Elorza, Setiembre D. | Gonzalez Rodulfo, Sara M. | Paulazo, Maria Alejandra | Ballestero, Jimena A. | Martin, Mauricio G. | Gómez Casati, María Eugenia
Abstract: ACUho:lePslteearsoelccoonnfitrrmibtuhtaetasllthoenaeduinrgolneavel lmsaermerbeprarneseenintetedgcorirtyre,cstulyp:ports membrane protein clustering and function, and facilitates proper signal transduction. Extensive evidence has shown that cholesterol imbalances in the central nervous system occur in aging and in the development of neurodegenerative diseases. In this work, we characterize cholesterol homeostasis in the inner ear of young and aged mice as a new unexplored possibility for the prevention and treatment of hearing loss. Our results show that cholesterol levels in the inner ear are reduced during aging, an effect that is associated with an increased expression of the cholesterol 24-hydroxylase (CYP46A1), the main enzyme responsible for cholesterol turnover in the brain. In addition, we show that pharmacological activation of CYP46A1 with the antiretroviral drug efavirenz reduces the cholesterol content in outer hair cells (OHCs), leading to a decrease in prestin immunolabeling and resulting in an increase in the distortion product otoacoustic emissions (DPOAEs) thresholds. Moreover, dietary supplementation with phytosterols, plant sterols with structure and function similar to cholesterol, was able to rescue the effect of efavirenz administration on the auditory function. Altogether, our findings point towards the importance of cholesterol homeostasis in the inner ear as an innovative therapeutic strategy in preventing and/or delaying hearing loss.
Afficher plus [+] Moins [-]Mots clés AGROVOC
Informations bibliographiques
Cette notice bibliographique a été fournie par Pontificia Universidad Católica Argentina
Découvrez la collection de ce fournisseur de données dans AGRIS